Light based anti-infectives: Ultraviolet C irradiation, photodynamic therapy, blue light, and beyond

Current Opinion in Pharmacology

Volumn 13, Issue 5, 2013, Pages 731-762

  Yin, Rui ^a,b,c   Dai, Tianhong ^a,b   Avci, Pinar ^a,b,d   Jorge, Ana Elisa Serafim ^a,e   De Melo, Wanessa C M A ^a,e   Vecchio, Daniela ^a,b   Huang, Ying Ying ^a,b,f   Gupta, Asheesh ^a,b,g   Hamblin, Michael R ^a,b,h  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f GUANGXI MEDICAL UNIVERSITY   (China)

^g DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

^h HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,7 BIS(N,N DIBUTYLAMINO)PHENOTHIAZINIUM BROMIDE; AMINOLEVULINIC ACID; ANTIINFECTIVE AGENT; CURCUMIN; ECHINOCANDIN; ERYTHROSINE; HYPOCRELLIN A; INDOLEACETIC ACID; LANTHANUM; METHYLENE BLUE; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PLACEBO; PPA 904; ROSE BENGAL; TEMOPORFIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ACANTHAMOEBA; ACNE VULGARIS; AEDES; ANOPHELES; ANTIBACTERIAL ACTIVITY; AQUACULTURE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL LOAD; BACTERICIDAL ACTIVITY; BIOFILM; BLUE LIGHT; CANDIDA ALBICANS; DISINFECTION; FOOD CONTROL; FUNGICIDAL ACTIVITY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; HELICOBACTER INFECTION; HERPES SIMPLEX; HUMAN; LEG ULCER; LEISHMANIA; LEISHMANIASIS; LIGHT EMITTING DIODE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIDRUG RESISTANCE; MYCOSIS; NONHUMAN; ONYCHOMYCOSIS; PAPILLOMAVIRUS INFECTION; PERIODONTITIS; PHOTODYNAMIC THERAPY; PLASMODIUM; PRIORITY JOURNAL; SEMLIKI FOREST ALPHAVIRUS; SKIN INJURY; TOENAIL ONYCHOMYCOSIS; TRICHOPHYTON RUBRUM; TRYPANOSOMA BRUCEI; ULTRAVIOLET C RADIATION; VESICULAR STOMATITIS VIRUS; WASTE WATER; WOUND CLOSURE; WOUND HEALING;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; LIGHT; MYCOSES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; VIRUS DISEASES;

EID: 84892982432     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.08.009     Document Type: Review

References (287)

1. Bell SG: Antibiotic resistance: is the end of an era near? Neonatal Netw 2003, 22: 47-54.
2. Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E et al.: Tackling antibiotic resistance. Nat Rev Microbiol 2011, 9: 894-896.
3. Dai T, Vrahas MS, Murray CK, Hamblin MR: Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Expert Rev Anti Infect Ther 2012, 10: 185-195.
4. Gurzadyan GG, Gorner H, Schulte-Frohlinde D: Ultraviolet (193, 216 and 254 nm) photoinactivation of Escherichia coli strains with different repair deficiencies. Radiat Res 1995, 141: 244-251.
5. Conner-Kerr TA, Sullivan PK, Gaillard J, Franklin ME, Jones RM: The effects of ultraviolet radiation on antibiotic-resistant bacteria in vitro. Ostomy Wound Manage 1998, 44: 50-56.
6. Su Y, Sun J, Rao S, Cai Y, Yang Y: Photodynamic antimicrobial activity of hypocrellin A. J Photochem Photobiol B 2011, 103: 29-34.
7. Dean SJ, Petty A, Swift S, McGhee JJ, Sharma A, Shah S, Craig JP: Efficacy and safety assessment of a novel ultraviolet C device for treating corneal bacterial infections. Clin Exp Ophthalmol 2011, 39: 156-163.
8. Bak J, Ladefoged SD, Tvede M, Begovic T, Gregersen A: Dose requirements for UVC disinfection of catheter biofilms. Biofouling 2009, 25: 289-296.
9. Dai T, Tegos GP, Rolz-Cruz G, Cumbie WE, Hamblin MR: Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis. Br J Dermatol 2008, 158: 1239-1246. (Pubitemid 351692876)
10. Sullivan PK, Conner-Kerr TA: A comparative study of the effects of UVC irradiation on select procaryotic and eucaryotic wound pathogens. Ostomy Wound Manage 2000, 46: 28-34.
11. Dai T, Kharkwal GB, Zhao J, St Denis TG, Wu Q, Xia Y, Huang L, Sharma SK, d'Enfert C, Hamblin MR: Ultraviolet-C light for treatment of Candida albicans burn infection in mice. Photochem Photobiol 2011, 87: 342-349.
12. Dai T, Murray CK, Vrahas MS, Baer DG, Tegos GP, Hamblin MR: Ultraviolet C light for Acinetobacter baumannii wound infections in mice: potential use for battlefield wound decontamination? J Trauma Acute Care Surg 2012, 73: 661-667.
13. Trevisan A, Piovesan S, Leonardi A, Bertocco M, Nicolosi P, Pelizzo MG, Angelini A: Unusual high exposure to ultraviolet-C radiation. Photochem Photobiol 2006, 82: 1077-1079. (Pubitemid 44460933)
14. Sosnin EA, Erofeev SE, Kieft MV, Kunts IESE: The effects of UV irradiation and gas plasma treatment on living mammalian cells and bacteria: a comparative approach. IEEE Trans Plasma Sci 2004, 32: 1544-1550.
15. Dai T, Tegos GP, St Denis TG, Anderson D, Sinofsky E, Hamblin MR: Ultraviolet-C irradiation for prevention of central venous catheter-related infections: an in vitro study. Photochem Photobiol 2011, 87: 250-255.
16. Mohr H, Steil L, Gravemann U, Thiele T, Hammer E, Greinacher A, Muller TH, Volker U: A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009, 49: 2612-2624.
17. Sterenborg HJ, van der Putte SC, van der Leun JC: The dose-response relationship of tumorigenesis by ultraviolet radiation of 254 nm. Photochem Photobiol 1988, 47: 245-253.
18. Young AR: Acute effects of UVR on human eyes and skin. Prog Biophys Mol Biol 2006, 92: 80-85. (Pubitemid 43842064)
19. Freytes HA, Fernandez B, Fleming WC: Ultraviolet light in the treatment of indolent ulcers. South Med J 1965, 58: 223-226.
20. Nussbaum EL, Biemann I, Mustard B: Comparison of ultrasound/ultraviolet-C and laser for treatment of pressure ulcers in patients with spinal cord injury. Phys Ther 1994, 74:812-823 (discussion 815-814).
21. Taylor GJ, Bannister GC, Leeming JP: Wound disinfection with ultraviolet radiation. J Hosp Infect 1995, 30: 85-93.
22. Thai TP, Houghton PE, Campbell KE, Woodbury MG: Ultraviolet light C in the treatment of chronic wounds with MRSA: a case study. Ostomy Wound Manage 2002, 48: 52-60.
23. Thai TP, Keast DH, Campbell KE, Woodbury MG, Houghton PE: Effect of ultraviolet light C on bacterial colonization in chronic wounds. Ostomy Wound Manage 2005, 51: 32-45.
24. Boker A, R-CG, Cumbie B, Kimball AB: A single-center, prospective, open-label, pilot study of the safety, local tolerability, and efficacy of ultraviolet-C (UVC) phototherapy for the treatment of great toenail onychomycosis. J Am Acad Dermatol 2007, 58:AB82.
25. Gupta A, Dai T, Avci P, Huang YY, Hamblin MR: Ultraviolet radiation in wound care: sterilization and stimulation. Adv Wound Care 2013 http://dx.doi.org/10.1089/wound.2012.0366. (in press).
26. Shimomura A, Tahara D, Tominaga M, Uchigiri S, Yamaguchi Y, Ishioka H, Nakahata A: The effect of ultraviolet rays on the prevention of exit-site infections. Adv Perit Dial 1995, 11: 152-156.
27. Foote CS: Definition of type I and type II photosensitized oxidation. Photochem Photobiol 1991, 54:659.
28. Tanielian C, Mechin R, Seghrouchni R, Schweitzer C: Mechanistic and kinetic aspects of photosensitization in the presence of oxygen. Photochem Photobiol 2000, 71: 12-19.
29. Ochsner M: Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B 1997, 39: 1-18. (Pubitemid 27285576)
30. Mitton D, Ackroyd R: A brief overview of photodynamic therapy in Europe. Photodiagnosis Photodyn Ther 2008, 5: 103-111.
31. Nitzan Y, Gutterman M, Malik Z, Ehrenberg B: Inactivation of Gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol 1992, 55: 89-96.
32. St Denis TG, Dai T, Izikson L, Astrakas C, Anderson RR, Hamblin MR, Tegos GP: All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence 2011, 2: 509-520.
33. Hamblin MR, Hasan T: Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci 2004, 3: 436-450. (Pubitemid 38855151)
34. Jori G, Fabris C, Soncin M, Ferro S, Coppellotti O, Dei D, Fantetti L, Chiti G, Roncucci G: Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers Surg Med 2006, 38: 468-481.
35. Malik Z, Ladan H, Nitzan Y: Photodynamic inactivation of Gram-negative bacteria: problems and possible solutions. J Photochem Photobiol B 1992, 14: 262-266.
36. Soncin M, Fabris C, Busetti A, Dei D, Nistri D, Roncucci G, Jori G: Approaches to selectivity in the Zn(II)-phthalocyanine- photosensitized inactivation of wild-type and antibiotic-resistant Staphylococcus aureus. Photochem Photobiol Sci 2002, 1: 815-819. (Pubitemid 37069803)
37. Tome JP, Neves MG, Tome AC, Cavaleiro JA, Soncin M, Magaraggia M, Ferro S, Jori G: Synthesis and antibacterial activity of new poly-S-lysine-porphyrin conjugates. J Med Chem 2004, 47: 6649-6652. (Pubitemid 39657326)
38. Schastak S, Ziganshyna S, Gitter B, Wiedemann P, Claudepierre T: Efficient photodynamic therapy against Gram-positive and Gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength. PLoS ONE 2010, 5:e11674.
39. Schastak S, Gitter B, Handzel R, Hermann R, Wiedemann P: Improved photoinactivation of Gram-negative and Gram-positive methicillin-resistant bacterial strains using a new near-infrared absorbing meso-tetrahydroporphyrin: a comparative study with a chlorine e6 photosensitizer photolon. Methods Find Exp Clin Pharmacol 2008, 30: 129-133. (Pubitemid 351756363)
40. Mantareva V, Kussovski V, Angelov I, Wohrle D, Dimitrov R, Popova E, Dimitrov S: Non-aggregated Ga(III)-phthalocyanines in the photodynamic inactivation of planktonic and biofilm cultures of pathogenic microorganisms. Photochem Photobiol Sci 2011, 10: 91-102.
41. Dai T, Tegos GP, Zhiyentayev T, Mylonakis E, Hamblin MR: Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg Med 2010, 42: 38-44.
42. Wainwright M, Phoenix DA, Gaskell M, Marshall B: Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp. J Antimicrob Chemother 1999, 44: 823-825.
43. Xing B, Jiang T, Bi W, Yang Y, Li L, Ma M, Chang CK, Xu B, Yeow EK: Multifunctional divalent vancomycin: the fluorescent imaging and photodynamic antimicrobial properties for drug resistant bacteria. Chem Commun (Camb) 2011, 47: 1601-1603.
44. Gad F, Zahra T, Hasan T, Hamblin MR: Effects of growth phase and extracellular slime on photodynamic inactivation of Gram-positive pathogenic bacteria. Antimicrob Agents Chemother 2004, 48: 2173-2178. (Pubitemid 38696911)
45. Nordmann P, Naas T, Fortineau N, Poirel L: Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr Opin Microbiol 2007, 10: 436-440. (Pubitemid 350064580)
46. Dijkshoorn L, Nemec A, Seifert H: An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5: 939-951. (Pubitemid 350131182)
47. Tseng SP, Teng LJ, Chen CT, Lo TH, Hung WC, Chen HJ, Hsueh PR, Tsai JC: Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa. Lasers Surg Med 2009, 41: 391-397.
48. Kussovski V, Mantareva V, Angelov I, Orozova P, Wohrle D, Schnurpfeil G, Borisova E, Avramov L: Photodynamic inactivation of Aeromonas hydrophila by cationic phthalocyanines with different hydrophobicity. FEMS Microbiol Lett 2009, 294: 133-140.
49. Trannoy LL, Terpstra FG, de Korte D, Lagerberg JW, Verhoeven AJ, Brand A, van Engelenburg FA: Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)- photoinactivation. Vox Sanguinis 2006, 91: 111-118. (Pubitemid 44126606)
50. Jassal M, Bishai WR: Extensively drug-resistant tuberculosis. Lancet Infect Dis 2009, 9: 19-30.
51. O'Riordan K, Sharlin DS, Gross J, Chang S, Errabelli D, Akilov OE, Kosaka S, Nau GJ, Hasan T: Photoinactivation of mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection. Antimicrob Agents Chemother 2006, 50: 1828-1834.
52. O'Riordan K, Akilov OE, Chang SK, Foley JW, Hasan T: Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection. Photochem Photobiol Sci 2007, 6: 1117-1123. (Pubitemid 47525007)
53. Wiegell SR, Kongshoj B, Wulf HC: Mycobacterium marinum infection cured by photodynamic therapy. Arch Dermatol 2006, 142: 1241-1242. (Pubitemid 44414422)
54. Shih MH, Huang FC: Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 2011, 52: 223-229.
55. Thota S, Wang M, Jeon S, Maragani S, Hamblin MR, Chiang LY: Synthesis and characterization of positively charged pentacationic [60]fullerene monoadducts for antimicrobial photodynamic inactivation. Molecules 2012, 17: 5225-5243.
56. Shrestha A, Kishen A: Polycationic chitosan-conjugated photosensitizer for antibacterial photodynamic therapy. Photochem Photobiol 2012, 88: 577-583.
57. Yang K, Gitter B, Ruger R, Albrecht V, Wieland GD, Fahr A: Wheat germ agglutinin modified liposomes for the photodynamic inactivation of bacteria. Photochem Photobiol 2012, 88: 548-556.
58. Yang K, Gitter B, Ruger R, Wieland GD, Chen M, Liu X, Albrecht V, Fahr A: Antimicrobial peptide-modified liposomes for bacteria targeted delivery of temoporfin in photodynamic antimicrobial chemotherapy. Photochem Photobiol Sci 2011, 10: 1593-1601.
59. Tsai T, Yang YT, Wang TH, Chien HF, Chen CT: Improved photodynamic inactivation of Gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles. Lasers Surg Med 2009, 41: 316-322.
60. Tsai T, Chien HF, Wang TH, Huang CT, Ker YB, Chen CT: Chitosan augments photodynamic inactivation of Gram-positive and Gram-negative bacteria. Antimicrob Agents Chemother 2011, 55: 1883-1890.
61. Orlandi VT, Caruso E, Banfi S, Barbieri P: Effect of organic matter on the in vitro photoeradication of Pseudomonas aeruginosa by means of a cationic tetraaryl-porphyrin. Photochem Photobiol 2012, 88: 557-564.
62. Walther J, Brocker MJ, Watzlich D, Nimtz M, Rohde M, Jahn D, Moser J: Protochlorophyllide: a new photosensitizer for the photodynamic inactivation of Gram-positive and Gram- negative bacteria. FEMS Microbiol Lett 2009, 290: 156-163.
63. Hamblin MR, Zahra T, Contag CH, McManus AT, Hasan T: Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis 2003, 187: 1717-1725. (Pubitemid 36667882)
64. Hamblin MR, O'Donnell DA, Murthy N, Contag CH, Hasan T: Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol 2002, 75: 51-57.
65. Dai T, Tegos GP, Lu Z, Huang L, Zhiyentayev T, Franklin MJ, Baer DG, Hamblin MR: Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother 2009, 53: 3929-3934.
66. Berthiaume F, Reiken SR, Toner M, Tompkins RG, Yarmush ML: Antibody-targeted photolysis of bacteria in vivo. Biotechnology (N Y) 1994, 12: 703-706.
67. Hashimoto MC, Prates RA, Kato IT, Nunez SC, Courrol LC, Ribeiro MS: Antimicrobial photodynamic therapy on drug-resistant Pseudomonas aeruginosa-induced infection. An in vivo study. Photochem Photobiol 2012, 88: 590-595.
68. Park JH, Ahn MY, Kim YC, Kim SA, Moon YH, Ahn SG, Yoon JH: In vitro and in vivo antimicrobial effect of photodynamic therapy using a highly pure chlorin e6 against Staphylococcus aureus Xen29. Biol Pharm Bull 2012, 35: 509-514.
69. Tanaka M, Kinoshita M, Yoshihara Y, Shinomiya N, Seki S, Nemoto K, Hamblin MR, Morimoto Y: Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect. Lasers Surg Med 2011, 43: 221-229.
70. Goto B, Iriuchishima T, Horaguchi T, Tokuhashi Y, Nagai Y, Harada T, Saito A, Aizawa S: Therapeutic effect of photodynamic therapy using Na-pheophorbide A on osteomyelitis models in rats. Photomed Laser Surg 2011, 29: 183-189.
71. Dortbudak O, Haas R, Bernhart T, Mailath-Pokorny G: Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis. Clin Oral Implants Res 2001, 12: 104-108. (Pubitemid 33723233)
72. Shibli JA, Martins MC, Theodoro LH, Lotufo RF, Garcia VG, Marcantonio EJ: Lethal photosensitization in microbiological treatment of ligature-induced peri-implantitis: a preliminary study in dogs. J Oral Sci 2003, 45: 17-23.
73. Hayek RR, Araujo NS, Gioso MA, Ferreira J, Baptista-Sobrinho CA, Yamada AM, Ribeiro MS: Comparative study between the effects of photodynamic therapy and conventional therapy on microbial reduction in ligature-induced peri-implantitis in dogs. J Periodontol 2005, 76: 1275-1281. (Pubitemid 41245770)
74. Komerik N, Nakanishi H, MacRobert AJ, Henderson B, Speight P, Wilson M: In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model. Antimicrob Agents Chemother 2003, 47: 932-940. (Pubitemid 36254218)
75. Sigusch BW, Pfitzner A, Albrecht V, Glockmann E: Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model. J Periodontol 2005, 76: 1100-1105. (Pubitemid 41065399)
76. Bottura PE, Milanezi J, Fernandes LA, Caldas HC, Abbud-Filho M, Garcia VG, Baptista MA: Nonsurgical periodontal therapy combined with laser and photodynamic therapies for periodontal disease in immunosuppressed rats. Transplant Proc 2011, 43: 2009-2016.
77. Fernandes LA, de Almeida JM, Theodoro LH, Bosco AF, Nagata MJ, Martins TM, Okamoto T, Garcia VG: Treatment of experimental periodontal disease by photodynamic therapy in immunosuppressed rats. J Clin Periodontol 2009, 36: 219-228.
78. de Almeida JM, Theodoro LH, Bosco AF, Nagata MJ, Bonfante S, Garcia VG: Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes. J Periodontol 2008, 79: 2156-2165.
79. de Almeida JM, Theodoro LH, Bosco AF, Nagata MJ, Oshiiwa M, Garcia VG: Influence of photodynamic therapy on the development of ligature-induced periodontitis in rats. J Periodontol 2007, 78: 566-575.
80. Seguier S, Souza SL, Sverzut AC, Simioni AR, Primo FL, Bodineau A, Correa VM, Coulomb B, Tedesco AC: Impact of photodynamic therapy on inflammatory cells during human chronic periodontitis. J Photochem Photobiol B 2010, 101: 348-354.
81. Wilson M, Mia N: Sensitisation of Candida albicans to killing by low-power laser light. J Oral Pathol Med 1993, 22: 354-357. (Pubitemid 23353475)
82. de Souza SC, Junqueira JC, Balducci I, Koga-Ito CY, Munin E, Jorge AO: Photosensitization of different Candida species by low power laser light. J Photochem Photobiol B 2006, 83: 34-38. (Pubitemid 43372640)
83. Junqueira JC, Martins Jda S, Faria RL, Colombo CE, Jorge AO: Photodynamic therapy for the treatment of buccal candidiasis in rats. Lasers Med Sci 2009, 24: 877-884.
84. Bliss JM, Bigelow CE, Foster TH, Haidaris CG: Susceptibility of Candida species to photodynamic effects of photofrin. Antimicrob Agents Chemother 2004, 48: 2000-2006. (Pubitemid 38691589)
85. Lazarova G: Effect of glutathione on Rose Bengal photosensitized yeast damage. Microbios 1993, 75: 39-43.
86. Bertoloni G, Rossi F, Valduga G, Jori G, Ali H, van Lier JE: Photosensitizing activity of water- and lipid-soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios 1992, 71: 33-46.
87. Dovigo LN, Pavarina AC, Mima EG, Giampaolo ET, Vergani CE, Bagnato VS: Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses 2011, 54: 123-130.
88. Teichert MC, Jones JW, Usacheva MN, Biel MA: Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002, 93: 155-160. (Pubitemid 41115718)
89. Giroldo LM, Felipe MP, de Oliveira MA, Munin E, Alves LP, Costa MS: Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans. Lasers Med Sci 2009, 24: 109-112.
90. Jackson Z, Meghji S, MacRobert A, Henderson B, Wilson M: Killing the yeast and hyphal forms of Candida albicans using a light-activated antimicrobial agent. Lasers Med Sci 1999, 14: 150-157. (Pubitemid 29338652)
91. Chabrier-Rosello Y, Foster TH, Mitra S, Haidaris CG: Respiratory deficiency enhances the sensitivity of the pathogenic fungus Candida to photodynamic treatment. Photochem Photobiol 2008, 84: 1141-1148.
92. Dovigo LN, Carmello JC, de Souza Costa CA, Vergani CE, Brunetti IL, Bagnato VS, Pavarina AC: Curcumin-mediated photodynamic inactivation of Candida albicans in a murine model of oral candidiasis. Med Mycol 2013, 51:243-251 http://dx.doi.org/10.3109/13693786.2012.714081.
93. Mima EG, Pavarina AC, Dovigo LN, Vergani CE, Costa CA, Kurachi C, Bagnato VS: Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109: 392-401.
94. Mima EG, Pavarina AC, Ribeiro DG, Dovigo LN, Vergani CE, Bagnato VS: Effectiveness of photodynamic therapy for the inactivation of Candida spp. on dentures: in vitro study. Photomed Laser Surg 2011, 29: 827-833.
95. Smijs TG, Schuitmaker HJ: Photodynamic inactivation of the dermatophyte Trichophyton rubrum. Photochem Photobiol 2003, 77: 556-560.
96. Smijs TG, van der Haas RN, Lugtenburg J, Liu Y, de Jong RL, Schuitmaker HJ: Photodynamic treatment of the dermatophyte Trichophyton rubrum and its microconidia with porphyrin photosensitizers. Photochem Photobiol 2004, 80: 197-202.
97. Denning DW: In Aspergillus species, edn 5. Edited by Mandell GL, Benett JE, Dolin R.Philadelphia: Churchill Livingstone; 2000.
98. Friedberg JS, Skema C, Baum ED, Burdick J, Vinogradov SA, Wilson DF, Horan AD, Nachamkin I: In vitro effects of photodynamic therapy on Aspergillus fumigatus. J Antimicrob Chemother 2001, 48: 105-107. (Pubitemid 32684732)
99. Jackson M, Flower CD, Shneerson JM: Treatment of symptomatic pulmonary aspergillomas with intracavitary instillation of amphotericin B through an indwelling catheter. Thorax 1993, 48: 928-930. (Pubitemid 23283389)
100. Gonzales FP, da Silva SH, Roberts DW, Braga GU: Photodynamic inactivation of conidia of the fungi Metarhizium anisopliae and Aspergillus nidulans with methylene blue and toluidine blue. Photochem Photobiol 2010, 86: 653-661.
101. Stewart PS, Costerton JW: Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358: 135-138. (Pubitemid 32709857)
102. Lewis K: Riddle of biofilm resistance. Antimicrob Agents Chemother 2001, 45: 999-1000.
103. O'Gara JP: ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 2007, 270: 179-188. (Pubitemid 46597372)
104. Sharma M, Visai L, Bragheri F, Cristiani I, Gupta PK, Speziale P: Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob Agents Chemother 2008, 52: 299-305.
105. Zanin IC, Goncalves RB, Junior AB, Hope CK, Pratten J: Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: an in vitro study. J Antimicrob Chemother 2005, 56: 324-330. (Pubitemid 41158520)
106. Zanin IC, Lobo MM, Rodrigues LK, Pimenta LA, Hofling JF, Goncalves RB: Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. Eur J Oral Sci 2006, 114: 64-69. (Pubitemid 43427122)
107. Pereira CA, Romeiro RL, Costa AC, Machado AK, Junqueira JC, Jorge AO: Susceptibility of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photodynamic inactivation: an in vitro study. Lasers Med Sci 2011, 26: 341-348.
108. Lin HY, Chen CT, Huang CT: Use of merocyanine 540 for photodynamic inactivation of Staphylococcus aureus planktonic and biofilm cells. Appl Environ Microbiol 2004, 70: 6453-6460.
109. Di Poto A, Sbarra MS, Provenza G, Visai L, Speziale P: The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. Biomaterials 2009, 30: 3158-3160.
110. Saino E, Sbarra MS, Arciola CR, Scavone M, Bloise N, Nikolov P, Ricchelli F, Visai L: Photodynamic action of tri-meso(N-methyl-pyridyl), meso(N-tetradecyl-pyridyl) porphine on Staphylococcus epidermidis biofilms grown on Ti6Al4V alloy. Int J Artif Organs 2010, 33: 636-645.
111. Wood S, Metcalf D, Devine D, Robinson C: Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J Antimicrob Chemother 2006, 57: 680-684.
112. Goulart Rde C, Thedei G Jr, Souza SL, Tedesco AC, Ciancaglini P: Comparative study of methylene blue and erythrosine dyes employed in photodynamic therapy for inactivation of planktonic and biofilm-cultivated Aggregatibacter actinomycetemcomitans. Photomed Laser Surg 2010, 28(Suppl. 1):S85-S90.
113. Lee CF, Lee CJ, Chen CT, Huang CT: delta-Aminolaevulinic acid mediated photodynamic antimicrobial chemotherapy on Pseudomonas aeruginosa planktonic and biofilm cultures. J Photochem Photobiol B 2004, 75: 21-25.
114. Collins TL, Markus EA, Hassett DJ, Robinson JB: The effect of a cationic porphyrin on Pseudomonas aeruginosa biofilms. Curr Microbiol 2010, 61: 411-416.
115. Hegge AB, Bruzell E, Kristensen S, Tonnesen HH: Photoinactivation of Staphylococcus epidermidis biofilms and suspensions by the hydrophobic photosensitizer curcumin - effect of selected nanocarrier: studies on curcumin and curcuminoides XLVII. Eur J Pharm Sci 2012, 47: 65-74.
116. Pereira CA, Costa AC, Carreira CM, Junqueira JC, Jorge AO: Photodynamic inactivation of Streptococcus mutans and Streptococcus sanguinis biofilms in vitro. Lasers Med Sci 2013, 28: 859-864.
117. Pereira Gonzales F, Maisch T: Photodynamic inactivation for controlling Candida albicans infections. Fungal Biol 2012, 116: 1-10.
118. Ramage G, Martinez JP, Lopez-Ribot JL: Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006, 6: 979-986. (Pubitemid 44568854)
119. Khan S, Alam F, Azam A, Khan AU: Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm. Int J Nanomedicine 2012, 7: 3245-3250.
120. Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D: Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat 2010, 13: 180-195.
121. Chabrier-Rosello Y, Foster TH, Perez-Nazario N, Mitra S, Haidaris CG: Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity. Antimicrob Agents Chemother 2005, 49: 4288-4290.
122. Costa AC, Rasteiro VM, Pereira CA, Rossoni RD, Junqueira JC, Jorge AO: The effects of Rose Bengal- and erythrosine- mediated photodynamic therapy on Candida albicans. Mycoses 2012, 55: 56-63.
123. Costa AC, de Campos Rasteiro VM, Pereira CA, da Silva Hashimoto ES, Beltrame M Jr, Junqueira JC, Jorge AO: Susceptibility of Candida albicans and Candida dubliniensis to erythrosine- and LED-mediated photodynamic therapy. Arch Oral Biol 2011, 56: 1299-1300.
124. Coleman JJ, Okoli I, Tegos GP, Holson EB, Wagner FF, Hamblin MR, Mylonakis E: Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol 2010, 5: 321-332.
125. Donnelly RF, McCarron PA, Tunney MM, David Woolfson A: Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J Photochem Photobiol B 2007, 86: 59-69. (Pubitemid 44835462)
126. Ribeiro AP, Andrade MC, da Silva Jde F, Jorge JH, Primo FL, Tedesco AC, Pavarina AC: Photodynamic inactivation of planktonic cultures and biofilms of Candida albicans mediated by aluminum-chloride-phthalocyanine entrapped in nanoemulsions. Photochem Photobiol 2013, 89: 111-119.
127. Soares BM, da Silva DL, Sousa GR, Amorim JC, de Resende MA, Pinotti M, Cisalpino PS: In vitro photodynamic inactivation of Candida spp. growth and adhesion to buccal epithelial cells. J Photochem Photobiol B 2009, 94: 65-70.
128. Biel MA: Photodynamic therapy of bacterial and fungal biofilm infections. Methods Mol Biol 2010, 635: 175-194.
129. Seneviratne CJ, Jin L, Samaranayake LP: Biofilm lifestyle of Candida: a mini review. Oral Dis 2008, 14: 582-590.
130. Douglas LJ: Candida biofilms and their role in infection. Trends Microbiol 2003, 11: 30-36. (Pubitemid 36084353)
131. Dai T, Fuchs BB, Coleman JJ, Prates RA, Astrakas C, St Denis TG, Ribeiro MS, Mylonakis E, Hamblin MR, Tegos GP: Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol 2012, 3:120.
132. Demidova TN, Hamblin MR: Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother 2005, 49: 2329-2335. (Pubitemid 40734462)
133. Illingworth CD, Cook SD: Acanthamoeba keratitis. Surv Ophthalmol 1998, 42: 493-508. (Pubitemid 28272739)
134. Jori G, Fabris C, Soncin M, Ferro S, Coppellotti O, Dei D, Fantetti L, Chiti G, Roncucci G: Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers Surg Med 2006, 38: 468-481.
135. Kassab K, Dei D, Roncucci G, Jori G, Coppellotti O: Phthalocyanine- photosensitized inactivation of a pathogenic protozoan, Acanthamoeba palestinensis. Photochem Photobiol Sci 2003, 2: 668-672. (Pubitemid 41646663)
136. Chen Z, Xuguang S, Zhiqun W, Ran L: In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Br J Ophthalmol 2008, 92: 1283-1290.
137. Mito T, Suzuki T, Kobayashi T, Zheng X, Hayashi Y, Shiraishi A, Ohashi Y: Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro. Invest Ophthalmol Vis Sci 2012, 53: 6305-6310.
138. Siddiqui R, Khan NA: Photochemotherapeutic strategies against Acanthamoeba keratitis. AMB Express 2012, 2:47.
139. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S: Cutaneous leishmaniasis. Lancet Infect Dis 2007, 7: 581-596. (Pubitemid 47277438)
140. Enk CD, Fritsch C, Jonas F, Nasereddin A, Ingber A, Jaffe CL, Ruzicka T: Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol 2003, 139: 432-434. (Pubitemid 36427606)
141. Song D, Lindoso JA, Oyafuso LK, Kanashiro EH, Cardoso JL, Uchoa AF, Tardivo JP, Baptista MS: Photodynamic therapy using methylene blue to treat cutaneous leishmaniasis. Photomed Laser Surg 2011, 29: 711-715.
142. Akilov OE, Kosaka S, O'Riordan K, Hasan T: Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation. Photochem Photobiol Sci 2007, 6: 1067-1070.
143. Akilov OE, Kosaka S, O'Riordan K, Hasan T: Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. Exp Dermatol 2007, 16: 651-660. (Pubitemid 47079595)
144. Akilov OE, Yousaf W, Lukjan SX, Verma S, Hasan T: Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis. Lasers Surg Med 2009, 41: 358-365.
145. Hernandez IP, Montanari J, Valdivieso W, Morilla MJ, Romero EL, Escobar P: In vitro phototoxicity of ultradeformable liposomes containing chloroaluminum phthalocyanine against New World Leishmania species. J Photochem Photobiol B 2012, 117C: 157-163.
146. Taylor VM, Cedeno DL, Munoz DL, Jones MA, Lash TD, Young AM, Constantino MH, Esposito N, Velez ID, Robledo SM: In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis. Antimicrob Agents Chemother 2011, 55: 4755-4760.
147. Gardlo K, Horska Z, Enk CD, Rauch L, Megahed M, Ruzicka T, Fritsch C: Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol 2003, 48: 893-896. (Pubitemid 36706223)
148. Stojiljkovic I, Evavold BD, Kumar V: Antimicrobial properties of porphyrins. Expert Opin Investig Drugs 2001, 10: 309-320. (Pubitemid 32117939)
149. Asilian A, Davami M: Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol 2006, 31: 634-637. (Pubitemid 44086787)
150. Baptista MS, Wainwright M: Photodynamic antimicrobial chemotherapy (PACT) for the treatment of malaria, leishmaniasis and trypanosomiasis. Braz J Med Biol Res 2011, 44: 1-10.
151. Lustigman S, Ben-Hur E: Photosensitized inactivation of Plasmodium falciparum in human red cells by phthalocyanines. Transfusion 1996, 36: 543-546. (Pubitemid 26234639)
152. Smith TG, Kain KC: Inactivation of Plasmodium falciparum by photodynamic excitation of heme-cycle intermediates derived from delta-aminolevulinic acid. J Infect Dis 2004, 190: 184-191. (Pubitemid 38858420)
153. Wagner SJ, Skripchenko A, Salata J, O'Sullivan AM, Cardo LJ: Inactivation of Leishmania donovani infantum and Trypanosoma cruzi in red cell suspensions with thiazole orange. Transfusion 2008, 48: 1363-1370.
154. Docampo R, Moreno SN, Gadelha FR, de Souza W, Cruz FS: Prevention of Chagas' disease resulting from blood transfusion by treatment of blood: toxicity and mode of action of gentian violet. Biomed Environ Sci 1988, 1: 406-413.
155. Docampo R, Moreno SN, Cruz FS: Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate. Mol Biochem Parasitol 1988, 27: 241-247.
156. Gottlieb P, Margolis-Nunno H, Robinson R, Shen LG, Chimezie E, Horowitz B, Ben-Hur E: Inactivation of Trypanosoma cruzi trypomastigote forms in blood components with a Psoralen and Ultraviolet A light. Photochem Photobiol 1996, 63: 562-565. (Pubitemid 126467129)
157. Gottlieb P, Shen LG, Chimezie E, Bahng S, Kenney ME, Horowitz B, Ben-Hur E: Inactivation of Trypanosoma cruzi trypomastigote forms in blood components by photodynamic treatment with phthalocyanines. Photochem Photobiol 1995, 62: 869-874.
158. Kasermann F, Kempf C: Photodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res 1997, 34: 65-70. (Pubitemid 27132858)
159. Kasermann F, Kempf C: Buckminsterfullerene and photodynamic inactivation of viruses. Rev Med Virol 1998, 8: 143-151. (Pubitemid 28393866)
160. Hirayama J, Abe H, Kamo N, Shinbo T, Ohnishi-Yamada Y, Kurosawa S, Ikebuchi K, Sekiguchi S: Photoinactivation of vesicular stomatitis virus with fullerene conjugated with methoxy polyethylene glycol amine. Biol Pharm Bull 1999, 22: 1106-1110.
161. Lin YL, Lei HY, Wen YY, Luh TY, Chou CK, Liu HS: Light-independent inactivation of dengue-2 virus by carboxyfullerene C3 isomer. Virology 2000, 275: 258-262.
162. Nims RW, Plavsic M: Polyomavirus inactivation - a review. Biologicals 2013, 41: 63-70.
163. Lee Y, Baron ED: Photodynamic therapy: current evidence and applications in dermatology. Semin Cutan Med Surg 2011, 30: 199-209.
164. Ben Amor T, Jori G: Sunlight-activated insecticides: historical background and mechanisms of phototoxic activity. Insect Biochem Mol Biol 2000, 30: 915-925.
165. Ben Amor T, Bortolotto L, Jori G: Porphyrins and related compounds as photoactivatable insecticides, 3. Laboratory and field studies. Photochem Photobiol 2000, 71: 124-128.
166. Lucantoni L, Magaraggia M, Lupidi G, Ouedraogo RK, Coppellotti O, Esposito F, Fabris C, Jori G, Habluetzel A: Novel, meso-substituted cationic porphyrin molecule for photo- mediated larval control of the dengue vector Aedes aegypti. PLoS Negl Trop Dis 2011, 5:e 1434.
167. Shao G, Jiang DX, Xu HH, Zeng W, Yu HJ, Tian YQ: Synthesis and photoactivated insecticidal activity of tetraethynylsilanes. J Photochem Photobiol B 2010, 98: 52-56.
168. Ling AE, Robbins KE, Brown TM, Dunmire V, Thoe SY, Wong SY, Leo YS, Teo D, Gallarda J, Phelps B et al.: Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA 2000, 284: 210-214. (Pubitemid 30460865)
169. Al Shaer L, Abdulrahman M, John TJ, Alhashimi A: Trends in prevalence, incidence, and residual risk of major transfusion- transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Transfusion 2012, 52: 2300-2309.
170. Aznar JA, Molina R, Montoro JM: Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma. Transfusion 1999, 39: 748-750. (Pubitemid 29328488)
171. Wainwright M: Pathogen inactivation in blood products. Curr Med Chem 2002, 9: 127-143. (Pubitemid 34436454)
172. Wagner SJ, Skripchenko A, Robinette D, Mallory DA, Hirayama J, Cincotta L, Foley J: The use of dimethylmethylene blue for virus photoinactivation of red cell suspensions. Dev Biol (Basel) 2000, 102: 125-129.
173. Skripchenko AA, Wagner SJ: Inactivation of WBCs in RBC suspensions by photoactive phenothiazine dyes: comparison of dimethylmethylene blue and MB. Transfusion 2000, 40: 968-975.
174. Hirayama J, Wagner SJ, Abe H, Ikebuchi K, Ikeda H: Involvement of reactive oxygen species in hemoglobin oxidation and virus inactivation by 1,9-dimethylmethylene blue phototreatment. Biol Pharm Bull 2001, 24: 418-421. (Pubitemid 32377612)
175. Schuyler R: Use of riboflavin for photoinactivation of pathogens in blood components. Transfus Apher Sci 2001, 25: 189-190. (Pubitemid 33122126)
176. Sobral PM, Barros AE, Gomes AM, do Bonfim CV: Viral inactivation in hemotherapy: systematic review on inactivators with action on nucleic acids. Rev Bras Hematol Hemoter 2012, 34: 231-235.
177. Antic A, Stanojkovic Z, Macukanovic-Golubovic L, Jelic M: Evaluation of coagulation factors in fresh frozen plasma treated with riboflavin and ultraviolet light. Vojnosanit Pregl 2012, 69: 22-26.
178. Stanojkovic Z, Antic A, Stojanovic M: Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates. Vojnosanit Pregl 2011, 68: 489-494.
179. Almeida A, Cunha A, Gomes NC, Alves E, Costa L, Faustino MA: Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants. Mar Drugs 2009, 7: 268-313.
180. Jori COG: Inactivation of pathogenic microorganisms by photodynamic techniques: mechanistic aspects and perspective applications. Anti-Infect Agents Med Chem 2007, 6: 119-131.
181. Magaraggia M, Faccenda F, Gandolfi A, Jori G: Treatment of microbiologically polluted aquaculture waters by a novel photochemical technique of potentially low environmental impact. J Environ Monit 2006, 8: 923-931. (Pubitemid 44327579)
182. Wong PN, Mak SK, Lo MW, Lo KY, Tong GM, Wong Y, Wong AK: Vibrio vulnificus peritonitis after handling of seafood in a patient receiving CAPD. Am J Kidney Dis 2005, 46: e87-e90. (Pubitemid 41505483)
183. Jemli M, Alouini Z, Sabbahi S, Gueddari M: Destruction of fecal bacteria in wastewater by three photosensitizers. J Environ Monit 2002, 4: 511-516. (Pubitemid 34864579)
184. Carvalho CM, Gomes AT, Fernandes SC, Prata AC, Almeida MA, Cunha MA, Tome JP, Faustino MA, Neves MG, Tome AC et al.: Photoinactivation of bacteria in wastewater by porphyrins: bacterial beta-galactosidase activity and leucine-uptake as methods to monitor the process. J Photochem Photobiol B 2007, 88: 112-118. (Pubitemid 47382614)
185. Alves E, Carvalho CM, Tome JP, Faustino MA, Neves MG, Tome AC, Cavaleiro JA, Cunha A, Mendo S, Almeida A: Photodynamic inactivation of recombinant bioluminescent Escherichia coli by cationic porphyrins under artificial and solar irradiation. J Ind Microbiol Biotechnol 2008, 35: 1447-1450.
186. Alves E, Costa L, Carvalho CM, Tome JP, Faustino MA, Neves MG, Tome AC, Cavaleiro JA, Cunha A, Almeida A: Charge effect on the photoinactivation of Gram-negative and Gram-positive bacteria by cationic meso-substituted porphyrins. BMC Microbiol 2009, 9:70.
187. Costa L, Carvalho CM, Faustino MA, Neves MG, Tome JP, Tome AC, Cavaleiro JA, Cunha A, Almeida A: Sewage bacteriophage inactivation by cationic porphyrins: influence of light parameters. Photochem Photobiol Sci 2010, 9: 1126-1130.
188. Alouini Z, Jemli M: Destruction of helminth eggs by photosensitized porphyrin. J Environ Monit 2001, 3: 548-551. (Pubitemid 32999902)
189. Bonnett R, Krysteva MA, Lalov IG, Artarsky SV: Water disinfection using photosensitizers immobilized on chitosan. Water Res 2006, 40: 1269-1270.
190. den Aantrekker ED, Boom RM, Zwietering MH, van Schothorst M: Quantifying recontamination through factory environments - a review. Int J Food Microbiol 2003, 80: 117-130.
191. Brovko LY, Meyer A, Tiwana AS, Chen W, Liu H, Filipe CD, Griffiths MW: Photodynamic treatment: a novel method for sanitation of food handling and food processing surfaces. J Food Prot 2009, 72: 1020-1030.
192. Tegos GP, Demidova TN, Arcila-Lopez D, Lee H, Wharton T, Gali H, Hamblin MR: Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol 2005, 12: 1127-1135. (Pubitemid 41483630)
193. Soukos NS, Ximenez-Fyvie LA, Hamblin MR, Socransky SS, Hasan T: Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother 1998, 42: 2595-2600.
194. Trindade FZ, Pavarina AC, Ribeiro AP, Bagnato VS, Vergani CE, Costa CA: Toxicity of photodynamic therapy with LED associated to Photogem(R): an in vivo study. Lasers Med Sci 2012, 27: 403-411.
195. Zeina B, Greenman J, Corry D, Purcell WM: Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes in vitro. Br J Dermatol 2002, 146: 568-573. (Pubitemid 34437766)
196. Tanaka M, Kinoshita M, Yoshihara Y, Shinomiya N, Seki S, Nemoto K, Hirayama T, Dai T, Huang L, Hamblin MR et al.: Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils. Photochem Photobiol 2012, 88: 227-232.
197. Shrestha A, Hamblin MR, Kishen A: Characterization of a conjugate between Rose Bengal and chitosan for targeted antibiofilm and tissue stabilization effects as a potential treatment of infected dentin. Antimicrob Agents Chemother 2012, 56: 4876-4880.
198. Qin Y, Luan X, Bi L, He G, Bai X, Zhou C, Zhang Z: Toluidine blue-mediated photoinactivation of periodontal pathogens from supragingival plaques. Lasers Med Sci 2008, 23: 49-54. (Pubitemid 350196867)
199. Dörtbudak O, Haas R, Bernhart T, Mailath-Pokorny G: Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis. Clin Oral Implants Res 2001, 12: 104-108. (Pubitemid 33723233)
200. Soukos NS, Chen PS, Morris JT, Ruggiero K, Abernethy AD, Som S, Foschi F, Doucette S, Bammann LL, Fontana CR et al.: Photodynamic therapy for endodontic disinfection. J Endod 2006, 32: 979-984. (Pubitemid 44374735)
201. Fontana CR, Abernethy AD, Som S, Ruggiero K, Doucette S, Marcantonio RC, Boussios CI, Kent R, Goodson JM, Tanner AC et al.: The antibacterial effect of photodynamic therapy in dental plaque-derived biofilms. J Periodontal Res 2009, 44: 751-759.
202. Williams JA, Pearson GJ, Colles MJ, Wilson M: The photo-activated antibacterial action of toluidine blue O in a collagen matrix and in carious dentine. Caries Res 2004, 38: 530-536. (Pubitemid 39482556)
203. Mima EG, Pavarina AC, Silva MM, Ribeiro DG, Vergani CE, Kurachi C, Bagnato VS: Denture stomatitis treated with photodynamic therapy: five cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 112: 602-608.
204. Mima EG, Vergani CE, Machado AL, Massucato EM, Colombo AL, Bagnato VS, Pavarina AC: Comparison of photodynamic therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial. Clin Microbiol Infect 2012, 18:E380-E388.
205. Lee JW, Kim BJ, Kim MN: Photodynamic therapy: new treatment for recalcitrant Malassezia folliculitis. Lasers Surg Med 2010, 42: 192-196.
206. Piraccini BM, Rech G, Tosti A: Photodynamic therapy of onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol 2008, 59:S75-S76.
207. Sotiriou E, Koussidou-Eremonti T, Chaidemenos G, Apalla Z, Ioannides D: Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: preliminary results of a single-centre open trial. Acta Derm Venereol 2010, 90: 216-217.
208. Calzavara-Pinton PG, Venturini M, Capezzera R, Sala R, Zane C: Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Photodermatol Photoimmunol Photomed 2004, 20: 144-147. (Pubitemid 38744932)
209. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR: Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000, 115: 183-192. (Pubitemid 30637186)
210. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A: Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol 2000, 136: 1093-1100.
211. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A: Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001, 144: 575-579. (Pubitemid 32232014)
212. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Carter LN: The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J Drugs Dermatol 2004, 3:S15-S19.
213. Yin R, Hao F, Deng J, Yang XC, Yan H: Investigation of optimal aminolaevulinic acid concentration applied in topical aminolaevulinic acid-photodynamic therapy for treatment of moderate to severe acne: a pilot study in Chinese subjects. Br J Dermatol 2010, 163: 1064-1070.
214. Kleinpenning MM, Smits T, Frunt MH, van Erp PE, van de Kerkhof PC, Gerritsen RM: Clinical and histological effects of blue light on normal skin. Photodermatol Photoimmunol Photomed 2010, 26: 16-21.
215. Darwin C: The Power of Movement in Plants. New York: Appleton and Company; 1881, .
216. De Lucca AJ, Carter-Wientjes C, Williams KA, Bhatnagar D: Blue light (470 nm) effectively inhibits bacterial and fungal growth. Lett Appl Microbiol 2012. [Epub ahead of print].
217. Ohm RA, Aerts D, Wosten HA, Lugones LG: The blue light receptor complex WC-1/2 of Schizophyllum commune is involved in mushroom formation and protection against phototoxicity. Environ Microbiol 2013, 15: 943-955.
218. Tschowri N, Lindenberg S, Hengge R: Molecular function and potential evolution of the biofilm-modulating blue light-signalling pathway of Escherichia coli. Mol Microbiol 2012, 85: 893-906.
219. Dai T, Gupta A, Murray CK, Vrahas MS, Tegos GP, Hamblin MR: Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resist Updat 2012, 15: 223-236.
220. Gomelsky M, Hoff WD: Light helps bacteria make important lifestyle decisions. Trends Microbiol 2011, 19: 441-448.
221. Purcell EB, Siegal-Gaskins D, Rawling DC, Fiebig A, Crosson S: A photosensory two-component system regulates bacterial cell attachment. Proc Natl Acad Sci U S A 2007, 104: 18241-18246. (Pubitemid 350210851)
222. van der Horst MA, Stalcup TP, Kaledhonkar S, Kumauchi M, Hara M, Xie A, Hellingwerf KJ, Hoff WD: Locked chromophore analogs reveal that photoactive yellow protein regulates biofilm formation in the deep sea bacterium Idiomarina loihiensis. J Am Chem Soc 2009, 131: 17443-17451.
223. Ondrusch N, Kreft J: Blue and red light modulates SigB-dependent gene transcription, swimming motility and invasiveness in Listeria monocytogenes. PLoS ONE 2011, 6:e16151.
224. Swartz TE, Tseng TS, Frederickson MA, Paris G, Comerci DJ, Rajashekara G, Kim JG, Mudgett MB, Splitter GA, Ugalde RA et al.: Blue-light-activated histidine kinases: two-component sensors in bacteria. Science 2007, 317: 1090-1100.
225. Ganz RA, Ahmad VJ, Ahmadi A, Khalil A, Tolkoff A, Nishioka MJ, Hamblin NSMR: Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med 2005, 36: 260-265. (Pubitemid 40578017)
226. Maclean M, MacGregor SJ, Anderson JG, Woolsey G: Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array. Appl Environ Microbiol 2009, 75: 1932-1940.
227. Murdoch LE, Maclean M, Endarko E, MacGregor SJ, Anderson JG: Bactericidal effects of 405 nm light exposure demonstrated by inactivation of Escherichia, Salmonella, Shigella, Listeria, and Mycobacterium species in liquid suspensions and on exposed surfaces. Sci World J 2012 2012:137805.
228. Jean D, Briolat V, Reysset G: Oxidative stress response in Clostridium perfringens. Microbiology 2004, 150: 1649-1650.
229. Murphy C, Carroll C, Jordan KN: Environmental survival mechanisms of the foodborne pathogen Campylobacter jejuni. J Appl Microbiol 2006, 100: 623-632.
230. Feuerstein O, Ginsburg I, Dayan E, Veler D, Weiss EI: Mechanism of visible light phototoxicity on Porphyromonas gingivalis and Fusobacterium nucleatum. Photochem Photobiol 2005, 81: 1186-1190.
231. Guffey JS, Wilborn J: In vitro bactericidal effects of 405-nm and 470-nm blue light. Photomed Laser Surg 2006, 24: 684-688. (Pubitemid 46106705)
232. Ashkenazi H, Malik Z, Harth Y, Nitzan Y: Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol 2003, 35: 17-24. (Pubitemid 36173500)
233. Fukui M, Yoshioka M, Satomura K, Nakanishi H, Nagayama M: Specific-wavelength visible light irradiation inhibits bacterial growth of Porphyromonas gingivalis. J Periodontal Res 2008, 43: 174-178.
234. Soukos NS, Som S, Abernethy AD, Ruggiero K, Dunham J, Lee C, Doukas AG, Goodson JM: Phototargeting oral black-pigmented bacteria. Antimicrob Agents Chemother 2005, 49: 1391-1400.
235. Nitzan Y, Salmon-Divon M, Shporen E, Malik Z: ALA induced photodynamic effects on Gram positive and negative bacteria. Photochem Photobiol Sci 2004, 3: 430-435. (Pubitemid 38855150)
236. Maclean M, MacGregor SJ, Anderson JG, Woolsey G: Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array. Appl Environ Microbiol 2009, 75: 1932-1940.
237. Takahama U, Shimizu-Takahama M, Egashira T: Reduction of exogenous cytochrome c by Neurospora crassa conidia: effects of superoxide dismutase and blue light. J Bacteriol 1982, 152: 151-156. (Pubitemid 13199058)
238. Casas-Flores S, Rios-Momberg M, Rosales-Saavedra T, Martinez-Hernandez P, Olmedo-Monfil V, Herrera-Estrella A: Cross talk between a fungal blue-light perception system and the cyclic AMP signaling pathway. Eukaryotic Cell 2006, 5: 499-506.
239. Purschwitz J, Muller S, Kastner C, Fischer R: Seeing the rainbow: light sensing in fungi. Curr Opin Microbiol 2006, 9: 566-571. (Pubitemid 44791993)
240. Oriel S, Nitzan Y: Photoinactivation of Candida albicans by its own endogenous porphyrins. Curr Microbiol 2010, 60: 117-123.
241. Hockberger PE, Skimina TA, Centonze VE, Lavin C, Chu S, Dadras S, Reddy JK, White JG: Activation of flavin-containing oxidases underlies light-induced production of H2O2 in mammalian cells. Proc Natl Acad Sci U S A 1999, 96: 6255-6260. (Pubitemid 29256652)
242. Wataha JC, Lockwood PE, Lewis JB, Rueggeberg FA, Messer RL: Biological effects of blue light from dental curing units. Dent Mater 2004, 20: 150-157.
243. Godley BF, Shamsi FA, Liang FQ, Jarrett SG, Davies S, Boulton M: Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J Biol Chem 2005, 280: 21061-21066. (Pubitemid 40805665)
244. Shnitkind E, Yaping E, Geen S, Shalita AR, Lee WL: Anti- inflammatory properties of narrow-band blue light. J Drugs Dermatol 2006, 5: 605-610.
245. Megraud F, Lamouliatte H: Review article: the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 2003, 17: 1333-1340.
246. Ganz RA, Viveiros J, Ahmad A, Ahmadi A, Khalil A, Tolkoff MJ, Nishioka NS, Hamblin MR: Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med 2005, 36: 260-265. (Pubitemid 40578017)
247. Lembo AJ, Ganz RA, Sheth S, Cave D, Kelly C, Levin P, Kazlas PT, Baldwin PC III, Lindmark WR, McGrath JR et al.: Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial. Lasers Surg Med 2009, 41: 337-344.
248. Bache SE, Maclean M, MacGregor SJ, Anderson JG, Gettinby G, Coia JE, Taggart I: Clinical studies of the High-Intensity Narrow-Spectrum light Environmental Decontamination System (HINS-light EDS), for continuous disinfection in the burn unit inpatient and outpatient settings. Burns 2012, 38: 69-76.
249. Maclean M, Macgregor SJ, Anderson JG, Woolsey GA, Coia JE, Hamilton K, Taggart I, Watson SB, Thakker B, Gettinby G: Environmental decontamination of a hospital isolation room using high-intensity narrow-spectrum light. J Hosp Infect 2010, 76: 247-251.
250. Shen N: Photodisruption in Biological Tissues Using Femtosecond Laser Pulses. Cambridge: Harvard University Press; 2003
251. Tsen KT, Chang TSW, Hung CL, Wu CF, Kiang TCJG: Inactivation of viruses with a very low power visible femtosecond laser. Virol J 2007, 4:50.
252. Tsen KT, Chang TSW, Hung CL, Wu CF, Kiang TCJG: Inactivation of viruses by laser-driven coherent excitations via impulsive stimulated Raman scattering process. J Biomed Opt 2007, 12:064030.
253. Tsen KT, Fu TS, Lindsay Q, Kibler SM, Jacobs K, Wu B, Karanam TC, Jagu B, Roden SRB et al.: Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laser. J Biomed Opt 2009, 14:064042.
254. Tsen KT, Chang TSWD, Hung CL, Wu CF, Kiang TCJG: Inactivation of viruses with a very low power visible femtosecond laser. J Phys: Condens Matter 2007, 19:322102.
255. Tsen KT, Sankey TSWD, Kiang OFJG: Selective inactivation of microorganisms with near-infrared femtosecond laser pulses. J Phys: Condens Matter 2007, 19:472201.
256. Tsen KT, Chang TSWD, Hung CL, Wu CF, Ramakrishna TC, Mossman B, Kiang KJG: Inactivation of viruses with a femtosecond laser via impulsive stimulated Raman scattering. Proc SPIE 2008, 6854:68540N.
257. Tsen SWD, Tsen TYSD, Wu KTTC: Selective inactivation of viruses with femtosecond laser pulses and its potential use for in vitro therapy. J Healthcare Eng 2010, 1: 185-196.
258. Tsen KT, Tsen SW, Fu Q, Lindsay SM, Li Z, Cope S, Vaiana S, Kiang JG: Studies of inactivation of encephalomyocarditis virus, M13 bacteriophage, and Salmonella typhimurium by using a visible femtosecond laser: insight into the possible inactivation mechanisms. J Biomed Opt 2011, 16:078003.
259. Tsen SW, Chapa T, Beatty W, Tsen KT, Yu D, Achilefu S: Inactivation of enveloped virus by laser-driven protein aggregation. J Biomed Opt 2012, 17:128002.
260. Manevitch Z, Lev D, Hochberg M, Palhan M, Lewis A, Enk CD: Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis. Photochem Photobiol 2010, 86: 476-479.
261. Denk W, Strickler JH, Webb WW: Two-photon laser scanning fluorescence microscopy. Science 1990, 248: 73-76.
262. Bornstein E, Hermans W, Gridley S, Manni J: Near-infrared photoinactivation of bacteria and fungi at physiologic temperatures. Photochem Photobiol 2009, 85: 1364-1370.
263. Krespi YP, Kizhner V: Laser-assisted nasal decolonization of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus. Am J Otolaryngol 2012, 33: 572-575.
264. Lauro FM, Pretto P, Covolo L, Jori G, Bertoloni G: Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates. Photochem Photobiol Sci 2002, 1: 468-470. (Pubitemid 41646498)
265. Tavares A, Carvalho CM, Faustino MA, Neves MG, Tome JP, Tome AC, Cavaleiro JA, Cunha A, Gomes NC, Alves E et al.: Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment. Mar Drugs 2010, 8: 91-105.
266. Giuliani F, Martinelli M, Cocchi A, Arbia D, Fantetti L, Roncucci G: In vitro resistance selection studies of RLP068/Cl, a new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy. Antimicrob Agents Chemother 2010, 54: 637-642.
267. Alcantara-Diaz D, Brena-Valle M, Serment-Guerrero J: Divergent adaptation of Escherichia coli to cyclic ultraviolet light exposures. Mutagenesis 2004, 19: 349-354. (Pubitemid 39405970)
268. Maclean M, Macgregor SJ, Anderson JG, Woolsey GA: The role of oxygen in the visible-light inactivation of Staphylococcus aureus. J Photochem Photobiol B 2008, 92: 180-184.
269. Wainwright M: 'Safe' photoantimicrobials for skin and soft-tissue infections. Int J Antimicrob Agents 2010, 36: 14-18.
270. Brown S: Clinical antimicrobial photodynamic therapy: phase II studies in chronic wounds. J Natl Compr Canc Netw 2012, 10(Suppl. 2):S80-S83.
271. Morley S, Griffiths J, Philips G, Moseley H, O'Grady C, Mellish K, Lankester CL, Faris B, Young RJ, Brown SB et al.: Phase IIa randomised, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonised, chronic leg ulcers and diabetic foot ulcers. A new approach to antimicrobial therapy. Br J Dermatol 2013, 168:617-624 http://dx.doi.org/10. 1111/bjd.12098.
272. Huh SY, Na JI, Huh CH, Park KC: The effect of photodynamic therapy using indole-3-acetic acid and green light on acne vulgaris. Ann Dermatol 2012, 24: 56-60.
273. Wang XL, Wang HW, Zhang LL, Guo MX, Huang Z: Topical ALA: PDT for the treatment of severe acne vulgaris. Photodiagnosis Photodyn Ther 2010, 7: 33-38.
274. Marotti J, Aranha AC, Eduardo Cde P, Ribeiro MS: Photodynamic therapy can be effective as a treatment for herpes simplex labialis. Photomed Laser Surg 2009, 27: 357-363.
275. Wang HW, Zhang LL, Miao F, Lv T, Wang XL, Huang Z: Treatment of HPV infection-associated cervical condylomata acuminata with 5-aminolevulinic acid-mediated photodynamic therapy. Photochem Photobiol 2012, 88: 565-569.
276. Wilder-Smith CH, Wilder-Smith P, Grosjean P, van den Bergh H, Woodtli A, Monnier P, Dorta G, Meister F, Wagnieres G: Photoeradication of Helicobacter pylori using 5- aminolevulinic acid: preliminary human studies. Lasers Surg Med 2002, 31: 18-22. (Pubitemid 34969114)
277. Novaes AB Jr, Schwartz-Filho HO, de Oliveira RR, Feres M, Sato S, Figueiredo LC: Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: microbiological profile. Lasers Med Sci 2012, 27: 389-395.
278. Feuerstein O, Persman N, Weiss EI: Phototoxic effect of visible light on Porphyromonas gingivalis and Fusobacterium nucleatum: an in vitro study. Photochem Photobiol 2004, 80: 412-415. (Pubitemid 40174462)
279. Enwemeka CS, Williams D, Hollosi S, Yens D, Enwemeka SK: Visible 405 nm SLD light photo-destroys methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Lasers Surg Med 2008, 40: 734-737.
280. Enwemeka CS, Williams D, Enwemeka SK, Hollosi S, Yens D: Blue 470-nm light kills methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Photomed Laser Surg 2009, 27: 221-226.
281. Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T: Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. J Dermatol Sci 2002, 30: 129-135. (Pubitemid 36159023)
282. Wheeland RG, Koreck A: Safety and effectiveness of a new blue light device for the self-treatment of mild-to-moderate acne. J Clin Aesthet Dermatol 2012, 5: 25-31.
283. Gold MH, Sensing W, Biron JA: Clinical efficacy of home-use blue-light therapy for mild-to moderate acne. J Cosmet Laser Ther 2011, 13: 308-314.
284. Wheeland RG, Dhawan S: Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system. J Drugs Dermatol 2011, 10: 596-602.
285. de Arruda LH, Kodani V, Bastos Filho A, Mazzaro CB: A prospective, randomized, open and comparative study to evaluate the safety and efficacy of blue light treatment versus a topical benzoyl peroxide 5% formulation in patients with acne grade II and III. Anais Brasil Dermatol 2009, 84: 463-468.
286. Tremblay JF, Sire DJ, Lowe NJ, Moy RL: Light-emitting diode 415 nm in the treatment of inflammatory acne: an open-label, multicentric, pilot investigation. J Cosmet Laser Ther 2006, 8: 31-33.
287. Morton CA, Scholefield RD, Whitehurst C, Birch J: An open study to determine the efficacy of blue light in the treatment of mild to moderate acne. J Dermatolog Treat 2005, 16: 219-223. (Pubitemid 41597534)